全文获取类型
收费全文 | 336篇 |
免费 | 27篇 |
专业分类
儿科学 | 83篇 |
妇产科学 | 1篇 |
基础医学 | 46篇 |
口腔科学 | 1篇 |
临床医学 | 22篇 |
内科学 | 108篇 |
神经病学 | 21篇 |
外科学 | 8篇 |
综合类 | 5篇 |
预防医学 | 26篇 |
眼科学 | 4篇 |
药学 | 5篇 |
肿瘤学 | 33篇 |
出版年
2023年 | 4篇 |
2021年 | 4篇 |
2020年 | 2篇 |
2019年 | 1篇 |
2018年 | 7篇 |
2017年 | 11篇 |
2016年 | 3篇 |
2015年 | 5篇 |
2014年 | 6篇 |
2013年 | 11篇 |
2012年 | 31篇 |
2011年 | 25篇 |
2010年 | 7篇 |
2009年 | 9篇 |
2008年 | 34篇 |
2007年 | 32篇 |
2006年 | 18篇 |
2005年 | 15篇 |
2004年 | 23篇 |
2003年 | 38篇 |
2002年 | 24篇 |
2001年 | 27篇 |
2000年 | 12篇 |
1999年 | 4篇 |
1998年 | 1篇 |
1997年 | 1篇 |
1994年 | 2篇 |
1992年 | 1篇 |
1989年 | 1篇 |
1988年 | 1篇 |
1981年 | 1篇 |
1978年 | 1篇 |
1977年 | 1篇 |
排序方式: 共有363条查询结果,搜索用时 15 毫秒
1.
Multi-locus analysis of HLA class II genes in DR2-positive IDDM haplotypes in Finland 总被引:1,自引:0,他引:1
Helena Reijonen Jorma Ilonen Hans K. Åkerblom Mikael Knip Hans-Michael Dosch "Childhood Diabetes in Finland" Study Group 《Tissue antigens》1994,43(1):1-6
Abstract: In this study we characterized the haplotypes found in IDDM patients that normally confer resistance to the disease in order to localize the polymorphisms relevant for the protection. We studied 15 DR2-positive subjects with IDDM for their DRB1, DRB5 and DQB1 genes using RFLP, polymerase chain reaction (PCR), oligonucleotide typing, and in some specific cases direct sequencing after allele-specific PCR. In addition we analyzed 39 DR2-positive, IDDM non-associated haplotypes representing those haplotypes that are not inherited to probands and hence are present only in healthy family members. The frequency of the DRB1*1501-DRB5*0101-DQB1*0602 haplotype was slightly decreased among diabetic patients (80% vs. 92%). In addition, two unconventional haplotypes DRB1*1501-DRB5*0101-DQB1*05031 and DRB1*1501-DRB5*0101-DQB1*0502 were found in patients with IDDM while all the control ones were conventional. The sequencing of the DQB1*0602 allele present in IDDM haplotypes showed no differences when compared to the controls. These results support the primary but not absolute role of DQ in the protection against IDDM. An additional role of factors centromeric to DQB1 gene was suggested by findings based on the biallelic TaqI RFLP polymorphism of the DQA2 gene. All DR2-DQB1*0602 IDDM haplotypes were associated with the 2.1-kb fragment while in the control group the 2.1-kb and 1.9-kb fragments were evenly distributed. 相似文献
2.
Kristiansen OP Karlsen AE Larsen ZM Johannesen J Pociot F Mandrup-Poulsen T;Danish IDDM Epidemiology Genetics Group Danish Study Group of IDDM in Childhood 《Scandinavian journal of immunology》2004,59(6):582-591
CD4 is a candidate gene in autoimmune diseases, including Type 1 diabetes mellitus (T1DM), because the CD4 receptor is crucial for appropriate antigen responses of CD4(+) T cells. We previously found linkage between a CD4-1188(TTTTC)(5-14) promoter polymorphism and T1DM. In the present study, we screened the human CD4 promoter for mutations and identified three frequent single nucleotide polymorphisms (SNPs): CD4-181C/G, CD4-521C/G and CD4-1050T/C. The SNPs are in strong linkage disequilibrium (LD) and association with the CD4-1188(TTTTC)(5-14) alleles, and we observed nine CD4 promoter haplotypes, of which four are frequent. We genotyped the SNPs in 253 Danish T1DM families (1129 individuals) and found evidence for linkage and association of a CD4 (A4(-1188)T(-1050)G(-521)C(-181)) haplotype to T1DM. In reporter studies, we show that (1) the T1DM-associated CD4 haplotype encodes high constitutive promoter activity and (2) the CD4-181G variant encodes higher stimulated promoter activity than the CD4-181C variant. This difference is in part neutralized in the frequently occurring CD4 promoter haplotypes by the more upstream genetic variants. Thus, we report functional impact of a novel CD4-181C/G SNP on stimulated CD4 promoter activity and the identification of a novel CD4 haplotype with high constitutive promoter activity that is linked and associated with T1DM. 相似文献
3.
4.
5.
Predictors of acquired lipodystrophy in juvenile-onset dermatomyositis and a gradient of severity 总被引:1,自引:0,他引:1
Bingham A Mamyrova G Rother KI Oral E Cochran E Premkumar A Kleiner D James-Newton L Targoff IN Pandey JP Carrick DM Sebring N O'Hanlon TP Ruiz-Hidalgo M Turner M Gordon LB Laborda J Bauer SR Blackshear PJ Imundo L Miller FW Rider LG;Childhood Myositis Heterogeneity Study Group 《Medicine》2008,87(2):70-86
We describe the clinical features of 28 patients with juvenile dermatomyositis (JDM) and 1 patient with adult-onset dermatomyositis (DM), all of whom developed lipodystrophy (LD) that could be categorized into 1 of 3 phenotypes, generalized, partial, or focal, based on the pattern of fat loss distribution. LD onset was often delayed, beginning a median of 4.6 years after diagnosis of DM. Calcinosis, muscle atrophy, joint contractures, and facial rash were DM disease features found to be associated with LD. Panniculitis was associated with focal lipoatrophy while the anti-p155 autoantibody, a newly described myositis-associated autoantibody, was more associated with generalized LD. Specific LD features such as acanthosis nigricans, hirsutism, fat redistribution, and steatosis/nonalcoholic steatohepatitis were frequent in patients with LD, in a gradient of frequency and severity among the 3 sub-phenotypes. Metabolic studies frequently revealed insulin resistance and hypertriglyceridemia in patients with generalized and partial LD. Regional fat loss from the thighs, with relative sparing of fat loss from the medial thighs, was more frequent in generalized than in partial LD and absent from DM patients without LD. Cytokine polymorphisms, the C3 nephritic factor, insulin receptor antibodies, and lamin mutations did not appear to play a pathogenic role in the development of LD in our patients. LD is an under-recognized sequela of JDM, and certain DM patients with a severe, prolonged clinical course and a high frequency of calcinosis appear to be at greater risk for the development of this complication. High-risk JDM patients should be screened for metabolic abnormalities, which are common in generalized and partial LD and result in much of the LD-associated morbidity. Further study is warranted to investigate the pathogenesis of acquired LD in patients with DM. 相似文献
6.
Progression of asthma measured by lung function in the childhood asthma management program 总被引:1,自引:0,他引:1
Covar RA Spahn JD Murphy JR Szefler SJ;Childhood Asthma Management Program Research Group 《American journal of respiratory and critical care medicine》2004,170(3):234-241
From the Childhood Asthma Management Program cohort, which was randomly assigned to receive budesonide, nedocromil, or placebo for 4-6 years, we determined the prevalence of and factors associated with at least 1% per year loss in postbronchodilator FEV(1)% predicted. Participants who had a significant reduction in postbronchodilator FEV(1)% predicted (SRP), comprised 25.7% of the cohort (n = 990). Using logistic regression, predictors of SRP at baseline were younger age (p = 0.0005), male sex (p < 0.0001), clinic (p = 0.02), and higher postbronchodilator FEV(1)% predicted (p = 0.02). Examination of the SRPs indicated that the effect of baseline lung function was such that the higher the lung function, the less steep the reduction in postbronchodilator FEV(1)% predicted (p < 0.0001). A similar proportion of SRPs was found in each treatment group. Among the SRPs, the rate of reduction in postbronchodilator FEV(1)% predicted was similar in all treatment groups. At a single site where biomarker assessment was performed, SRPs also had more prominent eosinophilic inflammation during the washout period. The course and mechanisms of lung function reduction or slow lung growth velocity in children with asthma must be defined. 相似文献
7.
Examination criteria and calibration procedures for prevention trials of the Early Childhood Caries Collaborating Centers
下载免费PDF全文
![点击此处可从《Journal of public health dentistry》网站下载免费的PDF全文](/ch/ext_images/free.gif)
8.
An overall characterization of pediatric acute lymphoblastic leukemia with CRLF2 overexpression
下载免费PDF全文
![点击此处可从《Genes, chromosomes & cancer》网站下载免费的PDF全文](/ch/ext_images/free.gif)
Mio Yano Toshihiko Imamura Daisuke Asai Akiko Moriya‐Saito So‐ichi Suenobu Daiichiro Hasegawa Takao Deguchi Yoshiko Hashii Hirohide Kawasaki Hiroki Hori Yoshiyuki Kosaka Koji Kato Keizo Horibe Keiko Yumura‐Yagi Junichi Hara Kenji Matsumoto Nobutaka Kiyokawa Megumi Oda Atsushi Sato for the Japan Association of Childhood Leukemia Study 《Genes, chromosomes & cancer》2014,53(10):815-823
9.
10.
Katrina Tatton‐Brown Anne Murray Sandra Hanks Jenny Douglas Ruth Armstrong Siddharth Banka Lynne M. Bird Carol L. Clericuzio Valerie Cormier‐Daire Tom Cushing Frances Flinter Marie‐Line Jacquemont Shelagh Joss Esther Kinning Sally Ann Lynch Alex Magee Vivienne McConnell Ana Medeira Keiichi Ozono Michael Patton Julia Rankin Debbie Shears Marleen Simon Miranda Splitt Volker Strenger Kyra Stuurman Clare Taylor Hannah Titheradge Lionel Van Maldergem I. Karen Temple Trevor Cole Sheila Seal Childhood Overgrowth Consortium Nazneen Rahman 《American journal of medical genetics. Part A》2013,161(12):2972-2980